Eotaxin-3 and interleukin-5 pleural fluid levels are associated with pleural fluid eosinophilia in post-coronary artery bypass grafting pleural effusions

Chest

Volumn 127, Issue 6, 2005, Pages 2094-2100

  Kalomenidis, Ioannis ^a   Stathopoulos, Georgios T ^c   Barnette, Randal ^d   Guo, Yubiao ^b   Peebles, R Stokes ^c   Blackwell, Timothy S ^c   Light, Richard W ^c  

^a EVANGELISMOS HOSPITAL   (Greece)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c VANDERBILT UNIVERSITY   (United States)

^d SAINT THOMAS HOSPITAL   (United States)

Author keywords

Eosinophilic pleural effusion; Eotaxin 3; Interleukin 5; Post coronary artery bypass grafting pleural effusion

Indexed keywords

EOTAXIN; EOTAXIN 3; INTERLEUKIN 5; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; BETA CHEMOKINE; BIOLOGICAL MARKER; CCL26 PROTEIN, HUMAN;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EOSINOPHIL; EOSINOPHILIA; HUMAN; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; COHORT ANALYSIS; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; CYTOLOGY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; MALE; METABOLISM; METHODOLOGY; NONPARAMETRIC TEST; POSTOPERATIVE COMPLICATION; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; CHEMOKINES, CC; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY DISEASE; EOSINOPHILIA; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTERLEUKIN-5; MALE; PLEURAL EFFUSION; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 21844438723     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.6.2094     Document Type: Article

References (18)

1. Kalomenidis, RW Light. Eosinophilic pleural effusions. Curr Opin Pulm Med 2003; 9:254-260
2. Sadikot RT, Rogers JT, Cheng DS, et al. Pleural fluid characteristics of patients with symptomatic pleural effusion after coronary artery bypass graft surgery. Arch Intern Med 2000; 160:2665-2668
3. Rothenberg ME. Mechanisms of disease: eosinophilia. N Engl J Med 1998; 338:1592-1600
4. Kalomenidis I, H Mohamed KH, Lane KB, et al. Pleural fluid levels of vascular cell adhesion molecule-1 are elevated in eosinophilic pleural effusions. Chest 2003; 124:159-166
5. Bandeira-Melo C, Herbst A, Weller PF. Eotaxins: contributing to the diversity of eosinophil recruitment and activation. Am J Respir Cell Mol Biol 2001; 24:653-657
6. Rothenberg ME, Zimmermann N, Mishra A, et al. Chemokines and chemokine receptors: their role in allergic airway diseases. J Clin Immunol 1999; 19:250-265
7. Bower G. Eosinophilic pleural effusion: a condition with multiple causes. Am Rev Respir Dis 1967; 95:746-751
8. Veress JF, Koss LG, Schrieber K. Eosinophilic pleural effusions. Acta Cytol 1979; 23:40-44
9. Maltais F, Laberge F, Cormier Y. Blood hypereosinophilia in the course of post-traumatic pleural effusion. Chest 1990; 98:348-351
10. Schandene L, Namias B, Crusiaux A, et al. IL-5 in post-traumatic eosinophilic pleural effusion. Clin Exp Immunol 1993; 93:115-119
11. Smit HJ, van den Heuvel MM, Barbierato SB, et al. Analysis of pleural fluid in idiopathic spontaneous pneumothorax: correlation of eosinophil percentage with the duration of air in the pleural space. Respir Med 1999; 93:262-267
12. Taniguchi H, Mukae H, Matsumoto N, et al. Elevated IL-5 levels in pleural fluid of patients with Paragonimiasis westermani. Clin Exp Immunol 2001; 123:94-98
13. Shinagawa K, Trifilieff A, Anderson GP. Involvement of CCR3-reactive chemokines in eosinophil survival. Int Arch Allergy Immunol 2003; 130:150-157
14. Yokoyama A, Kohno N, Ito M, et al. Eotaxin levels in pleural effusions: comparison with monocyte chemoattractant protein-1 and IL-8. Intern Med 2000; 39:547-552
15. Cuvelier SL, Patel KD. Shear-dependent eosinophil transmigration on interleukin 4-stimulated endothelial cells: a role for endothelium-associated eotaxin-3. J Exp Med 2001; 194: 1699-1709
16. Berkman N, Ohnona S, Chung FK, et al. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. Am J Respir Cell Mol Biol 2001; 24:682-687
17. Kagami S, Kakinuma T, Saeki H, et al. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/ CCL24, inpatients with atopic dermatitis: serum eotaxin-3/ CCL26 levels reflect the disease activity of atopic dermatitis. Clin Exp Immunol 2003; 134:309-313
18. Sadikot RT, Rogers JT, Cheng DS, et al. Pleural fluid characteristics of patients with symptomatic pleural effusion after coronary artery bypass graft surgery. Arch Intern Med 2000; 160:2665-2668